Ticker Symbol: ATNF
180 Life Sciences Corp
$4.04 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001690080
Company Profile
180 life sciences corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. its product development platforms in phase iib/iii clinical trials include fibrosis and anti-tnf platform, which focuses on fibrosis and anti-tumor necrosis factors; synthetic cannabidiol (cbd) analogs platform, which are man-made derivatives of cbd; and a7nachr platform, which focuses on alpha 7 nicotinic acetylcholine receptor. the company is headquartered in menlo park, california.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
CEO: N/A
Tags:
- Finance
- Financial Conglomerates
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.45
Change:
$0.00
(
1.01%)
Days Range: $0.35 - $0.47
Beta: 0.96
52wk. High: $11.18
52wk. Low: $0.37
Ytd. Change -85.72%
50 Day Moving Average: $0.59
200 Day Moving Average: $0.93
Shares Outstanding: 9932971
Valuation
Market Cap: 447.0M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A